节点文献

水痘疫苗免疫策略卫生经济学研究进展

Research progress on health economics of varicella vaccine immunization strategy

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 曹阳廖梦俊刘方贾滨

【Author】 CAO Yang;LIAO Mengjun;LIU Fang;JIA Bin;Beijing Chaoyang District Center for Disease Control and Prevention;

【通讯作者】 贾滨;

【机构】 北京市朝阳区疾病预防控制中心厦门大学公共卫生学院

【摘要】 水痘主要是通过呼吸道传播的急性传染病,是学校和托幼机构突发共卫生事件中的主要病因之一。水痘给个人和社会带来了严重的疾病负担,且我国水痘比已经纳入国家免疫规划(National Immunization Program,NIP)的其他疾病造成的经济负担高。预防水痘最经济有效的措施是接种水痘疫苗(varicella vaccine,VarV)。尽管目前水痘免疫策略在不同地区存在差异,但相比于不接种VarV,儿童和青少年的常规免疫接种符合经济学原则。我国VarV尚未纳入NIP,本研究拟综述水痘的流行病学特征、水痘对个人和社会造成的经济负担、VarV的接种程序以及不同免疫策略的经济效益及其影响因素,为制定科学的防控策略提供参考依据。

【Abstract】 Varicella, an acute infectious disease primarily transmitted through the respiratory tract, stands as a significant cause of public health emergencies in schools and childcare facilities. The burden of varicella on individuals and society is substantial, surpassing the economic impact of other diseases included in the National Immunization Program(NIP) in China. The administration of the varicella vaccine(VarV) is the most costeffective countermeasure. Although regional discrepancies exist in immunization strategies, routine immunization of children and adolescents with VarV is economically justified compared to non-vaccination. Given the exclusion of VarV from China’s NIP, this paper provides an extensive review of varicella’s epidemiological characteristics, its economic impact on individuals and society, VarV immunization procedures, and the costeffectiveness and determinants of various vaccination strategies. This review aims to provide a foundational reference for the development of evidence-based prevention and control strategies.

【基金】 北京市朝阳区科技计划项目(CYSF2104)
  • 【文献出处】 中国预防医学杂志 ,Chinese Preventive Medicine , 编辑部邮箱 ,2024年08期
  • 【分类号】R186.3;R511.5
  • 【下载频次】87
节点文献中: 

本文链接的文献网络图示:

本文的引文网络